Answer > on suicidality question of Patient Health Questionnaire (PHQ-) Depression Scale
Poorly controlled depressive symptoms, defined as a baseline score of or higher on the Patient Health Questionnaire (PHQ)- screening tool
or above on Patient Health Questionnaire (PHQ-) Depression Scale
> in PHQ- question
Patients with the following mood disorders as judged by the investigator or a psychiatrist, or as a result of patients mood assessment questionnaire:\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others) or patients with active severe personality disorders (defined according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition [DSM- IV]) are not eligible; Note: for patients with psychotropic treatments ongoing at baseline, the dose and the schedule should not be modified within the previous weeks prior to start of study drug\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety\r\n* Meets the cut-off score of >= in the Patient Health Questionnaire (PHQ)- or a cut-off of >= in the Generalized Anxiety Disorder (GAD)- mood scale, respectively, or selects a positive response of \, , or \ to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-)
Patients has any of the following mood disorders as judged by the Investigator or a Psychiatrist, or who meets the cut-off score of >= on the Patient Health Questionnaire (PHQ-) or a cut-off of >= in the Generalized Anxiety Disorder -item (GAD-) mood scale, respectively, or selects a positive response of , , or to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-)\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others)\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety\r\nNote: The psychiatric judgment overrules the mood assessment questionnaire result/investigators judgment
For participants on the BKM cohort only: \r\n* Any patient with a history of major depressive episode, bipolar disorder, obsessive/compulsive disorder, schizophrenia, a history of suicide attempt or ideation, or homicide/homicidal ideation as judged by the investigator and/or based on recent psychiatric assessment will not qualify for study participation\r\n* >= CTCAE grade anxiety at the time of study entry regardless of whether the anxiety is being treated with medications\r\n* Patients with the following mood disorders as judged by the investigator or a psychiatrist, or as a result of patients mood assessment questionnaire:\r\n** Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others)\r\n** >= CTCAE grade anxiety\r\n** Meets the cut-off score of >= in the Patient Health Questionnaire (PHQ)- or a cut-off of >= in the Generalized Anxiety Disorder (GAD)- mood scale, respectively, or selects a positive response of , , or to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-)
Patient has a score >= on the Patient Health Questionnaire (PHQ)- questionnaire
Patient selects a response of , or to question number on the PHQ- questionnaire regarding potential for suicidal thoughts or ideation (independent of the total score of the PHQ-)
Patients has any of the following mood disorders as judged by the Investigator or a psychiatrist, or who meets the cut-off score of >= the Patient Health Questionnaire- (PHQ-) or a cut-off of >= in the Generalized Anxiety Disorder (GAD-) mood scale, respectively, or selects a positive response of , , or to questions number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-)\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others)\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety\r\n* Note: the psychiatric judgment overrules the mood assessment questionnaire result or the investigators judgment
Patient has a score of >= on the Patient Health Questionnaire (PHQ)- questionnaire, selects a response of , or to question number on the PHQ- questionnaire regarding potential for suicidal thoughts or ideation (independent of the total score of the PHQ-), score >= on Generalized Anxiety Disorder (GAD)- mood scale
Patient has a score >= on the Patient Health Questionnaire (PHQ)- questionnaire
Patient selects a response of \, or \ to question number on the PHQ--questionaire regarding potential for suicidal thoughts or ideation (independent of the total score of the PHQ-)
Patients with the following mood disorders as judged by the Investigator or a psychiatrist, or as a result of patients mood assessment questionnaire:\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others) or patients with active severe personality disorders (defined according to Diagnostic and Statistical Manual [DSM]-IV) are not eligible; Note: for patients with psychotropic treatments ongoing at baseline, the dose and the schedule should not be modified within the previous weeks prior to start of study drug\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety \r\n* Meets the cut-off score of >= in the Patient Health Questionnaire -item (PHQ-) or a cut-off of >= in the Generalized Anxiety Disorder -item (GAD-) mood scale, respectively, or selects a positive response of , , or to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-)
Patients with active moderate or severe major mood or psychiatric disorder as judged by the investigator, primary care physician, counselor, psychiatrist, or as a result of the patients mood assessment questionnaire that may interfere with the ability to comply with the trial; in addition, given the prior mood-associated toxicities, patients with a history of psychiatric hospitalization within the past years, electroconvulsive therapy (ECT) within the past years, or whose psychiatric condition has been unstable within months prior to study enrollment requiring addition or change of psychotropic medications are not eligible; examples include, but are not limited to:\r\n* Medically documented history of or active major depressive episode requiring inpatient or intensive outpatient therapy, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or active ideation, or homicidal ideation (immediate risk of doing harm to others); patients under the care of a primary care physician who are treated with one oral agent and who have not required dose adjustments or new medications within months prior to study enrollment and who otherwise meet eligibility requirements may be enrolled\r\n* >= Common Terminology for Adverse Events (CTCAE) version . grade anxiety\r\n* Patients meeting the cutoff score of >= in the Patient Health Questionnaire- (PHQ-) or a cut-off of >= in the Generalized Anxiety Disorder- (GAD-) mood scale, respectively, or who select a positive response of \, , or \ to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-) are not eligible
Patients with the following mood disorders as judged by the Investigator or a psychiatrist, or as a result of patients mood assessment questionnaire (treating physician to decide on whether to administer questionnaire):\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others) or patients with active severe personality disorders (defined according to Diagnostic and Statistical Manual of Mental Disorders [DSM]-IV) are not eligible; Note: for patients with psychotropic treatments ongoing at baseline, the dose and the schedule should not be modified within the previous weeks prior to start of study drug\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) version (v) grade anxiety\r\n* Meets the cut-off score of >= in the Patient Health Questionnaire (PHQ-) or a cut-off of >= in the Generalized Anxiety Disorder (GAD-) mood scale, respectively, or selects a positive response of , , or to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-)
For Arms A, C or D, patients with the following mood disorders as judged by the investigator or a psychiatrist, or as result of patients mood assessment questionnaire:\r\n* Medically documented history of major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others) or patients with active severe personality disorders (defined according to Diagnostic and Statistical Manual of Mental Disorders [DSM]-IV); NOTE: for patients with psychotropic treatments ongoing at baseline, the dose and schedule should not be modified within the previous weeks prior to D of treatment with BKM\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety \r\n* At screening, meets the cut-off score of >= in the Patient Health Questionnaire (PHQ-) or a cut-off of >= in the Generalized Anxiety Disorder (GAD-) mood scale, respectively, or selects a positive response of , or to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-) will be excluded from the study unless overruled by the psychiatric assessment\r\n* Note: The psychiatric judgment overrules the mood assessment questionnaire result/investigator's judgment
Patients with the following mood disorders as judged by the Investigator or a psychiatrist, or as a result of patients mood assessment questionnaire:\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others)\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety\r\n* Meets the cut-off score of >= in the Patient Health Questionnaire (PHQ)- or a cut-off of >= in the Generalized Anxiety Disorder -item (GAD-) mood scale, respectively, or selects a positive response of , , or to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-)
Patients have any of the following mood disorders as judged by the Investigator or a Psychiatrist, or who meets the cut-off score of ? the PHQ- or a cut-off of ? in the GAD- mood scale, respectively, or selects a positive response of ', , or ' to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-) see Appendix .
Following mood disorders as judged by the investigator and/or symptom management service co-investigator, or as a result of patients mood assessment questionnaire:\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others)\r\n* Current >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety\r\n* Meets the cut-off score of >= in the Patient Health Questionnaire- (PHQ-) or a cut-off of >= in the Generalized Anxiety Disorder -item (GAD-) mood scale, respectively, or selects a positive response of , , or to question number regarding potential for suicidal thoughts in the PHQ- (independent of the total score of the PHQ-) will be excluded from the study
Patient has a score ? on the PHQ- questionnaire.
Patient has any of the following baseline mood disorders (not attributable to GBM) as judged by the Investigator or a Psychiatrist, or meets the cut-off score of ? in the PHQ- or a cut-off of ? in the GAD- mood scale for reasons not attributable to GBM; or selects a positive response of ', , ' to question number regarding potential for suicidal thoughts or ideation in the PHQ- (independent of the total score of the PHQ-)
Patients with the following mood disorders as judged by the Investigator or a psychiatrist, or as result of patient's mood assessment questionnaire:\r\n* Medically documented history of or active major depressive episode, bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history of suicidal attempt or ideation, or homicidal ideation (immediate risk of doing harm to others)\r\n* >= Common Terminology Criteria for Adverse Events (CTCAE) grade anxiety\r\n* At screening, mood rating scores of >= on Patient Health Questionnaire (PHQ)- and/or >= on Generalized Anxiety Disorder Scale (GAD)-, unless overruled by psychiatrist's assessment\r\n* Patient selects a response of \, , or \ for question on PHQ- questionnaire regarding potential for suicidal thoughts or ideation (independent of the total score of the PHQ-)\r\n* NOTE: the psychiatric judgment overrules the mood assessment questionnaire result/investigators judgment; if mood rating scores do not meet eligibility criteria and/or the investigator deems that a patient has mood disorder that renders the patient ineligible, that patient may not be registered to the study unless there is a subsequent psychiatric clinic consultation in which the psychiatrist overrules the mood assessment questionnaire result/investigator judgment
Patient has a score >= on the Patient Health Questionnaire (PHQ)- questionnaire
Patient selects a response of , or to question number on the PHQ- questionnaire regarding potential for suicidal thoughts or ideation (independent of the total score of the PHQ-)
Score of < on the PHQ-
No suicidal thoughts as indicated by a positive (+) response to question on the PHQ
Score >= on the Generalized Anxiety Disorder- Questionnaire (GAD-) and/or a score >= on the Patient Health Questionnaire- Item (PHQ-), indicating clinically significant anxiety or depressive symptoms, respectively
Having a psychotic disorder or the presence of another psychiatric condition (e.g., severe depression [i.e., > on the Patient Health Questionnaire- [PHQ-]], suicidal ideation) or cognitive impairment (e.g., severe dyslexia, traumatic brain injury) limiting ability to give consent and/or participate fully in the study
Positive depression screen (PHQ- score >= ) or current antidepressant treatment
A score of or more on the Patient Health Questionnaire (PHQ-) on the first visit
Severe depression (Patient Health Questionnaire [PHQ]- >= )
Suicidal ideation, as determined via Patient Health Questionnaire (PHQ)-
Currently elevated depressive symptoms; (Patient Health Questionnaire [PHQ] > )
Meeting criteria for a current major depressive episode measured by the PHQ-